ATE497493T1 - Neues zwischenprodukt zur herstellung von montelukast und verwandten verbindungen - Google Patents

Neues zwischenprodukt zur herstellung von montelukast und verwandten verbindungen

Info

Publication number
ATE497493T1
ATE497493T1 AT06818694T AT06818694T ATE497493T1 AT E497493 T1 ATE497493 T1 AT E497493T1 AT 06818694 T AT06818694 T AT 06818694T AT 06818694 T AT06818694 T AT 06818694T AT E497493 T1 ATE497493 T1 AT E497493T1
Authority
AT
Austria
Prior art keywords
intermediate product
related compounds
new intermediate
producing montelukast
montelukast
Prior art date
Application number
AT06818694T
Other languages
English (en)
Inventor
Arjanne Overeem
Lambertus Thijs
Petr Benovsky
Jakub Castulik
Jie Zhu
Petr Bartos
Radomir Skoumal
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Application granted granted Critical
Publication of ATE497493T1 publication Critical patent/ATE497493T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/75—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT06818694T 2005-11-18 2006-11-20 Neues zwischenprodukt zur herstellung von montelukast und verwandten verbindungen ATE497493T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73775205P 2005-11-18 2005-11-18
US79442906P 2006-04-24 2006-04-24
US82438206P 2006-09-01 2006-09-01
PCT/EP2006/011134 WO2007057228A1 (en) 2005-11-18 2006-11-20 A new intermediate for making montelukast and related compounds

Publications (1)

Publication Number Publication Date
ATE497493T1 true ATE497493T1 (de) 2011-02-15

Family

ID=37685804

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06818694T ATE497493T1 (de) 2005-11-18 2006-11-20 Neues zwischenprodukt zur herstellung von montelukast und verwandten verbindungen

Country Status (12)

Country Link
US (5) US7601741B2 (de)
EP (3) EP1954679B1 (de)
JP (1) JP2009515922A (de)
AR (3) AR057909A1 (de)
AT (1) ATE497493T1 (de)
AU (3) AU2006314728A1 (de)
CA (3) CA2629834A1 (de)
DE (1) DE602006019979D1 (de)
IL (1) IL185129A0 (de)
NO (1) NO20074188L (de)
PT (1) PT1954679E (de)
WO (3) WO2007057227A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006054317A1 (en) * 2004-11-19 2006-05-26 Matrix Laboratories Ltd Process for the preparation of novel amorphous montelukast sodium
ES2358923T3 (es) 2005-07-05 2011-05-16 Teva Pharmaceutical Industries, Ltd. Purificación de montelukast.
AR057909A1 (es) * 2005-11-18 2007-12-26 Synthon Bv Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico.
EP2014650A1 (de) * 2007-07-13 2009-01-14 Lonza Ag Verfahren und Zwischenprodukt zur Herstellung eines Zwischenprodukts bei der Herstellung von Montelukast
ES2320077B1 (es) 2007-07-31 2010-02-26 Moehs Iberica, S.L. Proceso de preparacion de un antagonista de leucotrienos y de un intermedio del mismo.
CN102046602A (zh) * 2008-04-25 2011-05-04 斯索恩有限公司 制备孟鲁司特中间体的方法
EP2552892A1 (de) 2010-03-31 2013-02-06 KRKA, D.D., Novo Mesto Effiziente synthese zur herstellung von montelukast und neue kristalline form von zwischenprodukten darin
EP2566474B1 (de) 2010-05-03 2017-11-15 Teikoku Pharma USA, Inc. Nichtwässrige taxan-pro-emulsionsformulierungen sowie verfahren zu ihrer herstellung und verwendung
TWI450275B (zh) * 2010-05-19 2014-08-21 Wistron Corp 可提升寫入保護之記憶體系統及相關方法
US8471030B2 (en) 2010-12-06 2013-06-25 Orochem Technologies Inc. Purification of montelukast using simulated moving bed
EP2502910A1 (de) 2011-03-15 2012-09-26 Laboratorios Lesvi, S.L. Camphersulfonsalz eines Montelukastschlüssels Zwischenprodukt
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU199796B (en) * 1985-08-06 1990-03-28 Boehringer Biochemia Srl Process for producing 2-thiomethyl-substituted-1,4-dihydropyridines and pharmaceutical compositions comprising such compounds
CA2038178A1 (en) 1990-04-05 1991-10-06 Carl C. Greco Niobium alkoxyalkoxides and process for formation
CA2053216C (en) * 1990-10-12 2003-04-08 Michel L. Belley Saturated hydroxyalkylquinoline acids as leukotriene antagonists
US5565473A (en) 1990-10-12 1996-10-15 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
US5856322A (en) 1990-10-12 1999-01-05 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
CA2053209C (en) 1990-10-12 1998-12-08 Michel L. Belley Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
US5266568A (en) 1990-10-12 1993-11-30 Merck Frosst Canada, Inc. Hydroxyalkylquinoline ether acids as leukotriene antagonists
IE920499A1 (en) * 1991-02-21 1992-08-26 Merck Frosst Canada Inc Quinoline-containing ketoacids as leukotriene antagonists
US5270324A (en) 1992-04-10 1993-12-14 Merck Frosst Canada, Inc. Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
TW448160B (en) 1993-12-28 2001-08-01 Merck & Co Inc Novel dicyclohexylamine salt and process for the preparation of leukotriene antagonists
GB9423511D0 (en) 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
US5585115A (en) 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5523477A (en) 1995-01-23 1996-06-04 Merck & Co., Inc. Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid
US5869673A (en) 1997-02-28 1999-02-09 Merck & Co., Inc. Process for 3-(2-(7-chloro-2-quinolinyl)ethenyl) - benzaldehyde
CN1420113A (zh) 2001-11-16 2003-05-28 北京上地新世纪生物医药研究所 孟鲁司特钠的制备方法及其制备中间体
CN1171873C (zh) * 2001-12-26 2004-10-20 北京上地新世纪生物医药研究所 一种孟鲁司特钠的制备方法及其制备中间体
US20050107612A1 (en) * 2002-12-30 2005-05-19 Dr. Reddy's Laboratories Limited Process for preparation of montelukast and its salts
US20040265375A1 (en) 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
ES2371549T3 (es) 2003-10-10 2012-01-05 Synthon B.V. Montelukast en estado sólido.
WO2005074935A1 (en) * 2004-01-30 2005-08-18 Teva Pharmaceutical Industries Ltd. Montelukast free acid polymorphs
US7189853B2 (en) * 2004-04-15 2007-03-13 Dr. Reddy's Laboratories Limited Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (Montelukast) and its pharmaceutically acceptable salts
US7829716B2 (en) * 2004-04-30 2010-11-09 Synthon Pharmaceuticals, Inc. Process for making montelukast and intermediates therefor
US7501517B2 (en) * 2004-04-30 2009-03-10 Synthon Ip, Inc. Process for making montelukast and intermediates therefor
ATE500225T1 (de) * 2004-07-19 2011-03-15 Matrix Lab Ltd Verfahren zur herstellung von montelukast und salzen davon
ITMI20050247A1 (it) * 2005-02-18 2006-08-19 Chemi Spa Processo per la preparazione di montelukast
AR057909A1 (es) * 2005-11-18 2007-12-26 Synthon Bv Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico.

Also Published As

Publication number Publication date
AR056815A1 (es) 2007-10-24
US20070135643A1 (en) 2007-06-14
AR057908A1 (es) 2007-12-26
WO2007057225A3 (en) 2007-07-26
EP1960362A1 (de) 2008-08-27
US20090093636A1 (en) 2009-04-09
JP2009515922A (ja) 2009-04-16
WO2007057227A1 (en) 2007-05-24
US7476748B2 (en) 2009-01-13
PT1954679E (pt) 2011-05-05
WO2007057228A1 (en) 2007-05-24
EP1948610A2 (de) 2008-07-30
CA2598093A1 (en) 2007-05-24
US20100099879A1 (en) 2010-04-22
US7601741B2 (en) 2009-10-13
NO20074188L (no) 2008-08-13
US20070135480A1 (en) 2007-06-14
CA2629840A1 (en) 2007-05-24
EP1954679A1 (de) 2008-08-13
US20070135642A1 (en) 2007-06-14
DE602006019979D1 (de) 2011-03-17
CA2629834A1 (en) 2007-05-24
AR057909A1 (es) 2007-12-26
EP1954679B1 (de) 2011-02-02
AU2006314729A1 (en) 2007-05-24
WO2007057225A2 (en) 2007-05-24
AU2006314728A1 (en) 2007-05-24
AU2006314726A1 (en) 2007-05-24
IL185129A0 (en) 2007-12-03
US7786138B2 (en) 2010-08-31

Similar Documents

Publication Publication Date Title
ATE497493T1 (de) Neues zwischenprodukt zur herstellung von montelukast und verwandten verbindungen
NO20070753L (no) Fremgangsmåte for fremstilling av dihydropteridinoner
DE602006018429D1 (de) Verfahren zur herstellung von verschlüssen
DE502006001614D1 (de) Verfahren zur herstellung von 1-alkyl-3-phenyluracilen
DE602007013512D1 (de) Verfahren zur kontinuierlichen Herstellung von Bauteilen
DE602005026987D1 (de) Verfahren zur herstellung von 1,2-dichlorethan
DE502006008840D1 (de) Verfahren zur Herstellung von Isocyanaten
DE602006006237D1 (de) Verfahren zur Herstellung von keramischen Heizern
DE502006006498D1 (de) Verfahren zur Herstellung von Organopolysiloxanen
DE502006000138D1 (de) Verfahren zur Herstellung von Triorganosiloxygruppen aufweisenden Organopolysiloxanen
DE602008005919D1 (de) Verfahren zur herstellung von teeprodukten und hierdurch erhältliche produkte
DE602006004680D1 (de) Maschine zur Herstellung von Mehrfachfiltern
NO20076030L (no) Fremgangsmåte for fremstilling av hydroklorsilaner
DE602006010302D1 (de) Verfahren zur Herstellung von 5-methyl-2-furfural
DE502006000036D1 (de) Kontinuierliches Verfahren zur Herstellung SiOC-enthaltender Verbindungen
DE112008000701A5 (de) Zusammensetzung zur Herstellung von Speisern
DE502006001472D1 (de) Verfahren zur kontinuierlichen Herstellung von hochviskosen vernetzbaren Siliconmassen
ATE461919T1 (de) Verfahren zur herstellung von montelukast und zwischenprodukte dafür
DE602006009562D1 (de) Verfahren zur herstellung von ferrisuccinylcasein
DE602006001531D1 (de) Verfahren zur Herstellung von Cyclohexanon-oxim
DE602006018699D1 (de) Verfahren zur Herstellung von Fluorhalogenethern
DE502006004187D1 (de) Verfahren zur herstellung von diorganopolysiloxanen
DE112006000985A5 (de) Verfahren zur Herstellung von Tetrahydropyranen aus Tetrahydropyran-3-onen
ATE552250T1 (de) Verfahren zur herstellung von duloxetin und verwandten verbindungen
DE602006004360D1 (de) Verfahren zur herstellung von amorolfin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties